Patents by Inventor Masachika Azuma

Masachika Azuma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8540987
    Abstract: Provided herein is a means which is effective for botulism diseases and the prevention of the botulism diseases. Specifically provided is a plurality of human anti-botulinum toxin type-A antibodies having different epitopes from one another. Also specifically provided is a composition for neutralizing botulinum toxin type-A, which comprises a combination of two or more of the antibodies and which has a high neutralizing activity.
    Type: Grant
    Filed: January 23, 2009
    Date of Patent: September 24, 2013
    Assignees: Institute for Antibodies Co., Ltd., Japan as Represented by Director-General of National Institute of Infectious Diseases, Osaka Prefecture University Public Corporation
    Inventors: Masachika Azuma, Motohide Takahashi, Shunji Kozaki, Masafumi Mukamoto, Tomoko Kohda, Gene Kurosawa, Yoshikazu Kurosawa
  • Publication number: 20120046451
    Abstract: It is intended to clarify a molecule which is available as a target in treating or diagnosing cancer and utilize the molecule in the medical field or the research field. By treating IgSF4, which has been identified as a molecule specifically expressed in lung cancer cells, with an antibody, and ADCC activity is exerted. Based on this finding, an anti-IgSF4 antibody is provided as a means efficacious in treating cancer, etc.
    Type: Application
    Filed: September 21, 2011
    Publication date: February 23, 2012
    Applicants: Institute for Antibodies Co., Ltd.
    Inventors: Yoshikazu Kurosawa, Yasushi Akahori, Nobuhiro Takahashi, Atsushi Sugioka, Nobuhiro Hayashi, Akihiko Takasaki, Kazuhiro Suzuki, Miwa Morita, Gene Kurosawa, Sari Fujiyama, Susumu Tsutsumi, Keiko Ogawa, Kazuki Matsuda, Chiho Muramatsu, Yoshitaka Iba, Mariko Sumitomo, Masachika Azuma, Yoshinori Ukai, Kazuhiro Morishita
  • Patent number: 8048992
    Abstract: It is intended to clarify a molecule which is available as a target in treating or diagnosing cancer and utilize the molecule in the medical field or the research field. By treating IgSF4, which has been identified as a molecule specifically expressed in lung cancer cells, with an antibody, and ADCC activity is exerted. Based on this finding, an anti-IgSF4 antibody is provided as a means efficacious in treating cancer, etc.
    Type: Grant
    Filed: February 22, 2006
    Date of Patent: November 1, 2011
    Assignees: Institute for Antibodies Co., Ltd.
    Inventors: Yoshikazu Kurosawa, Yasushi Akahori, Nobuhiro Takahashi, Atsushi Sugioka, Nobuhiro Hayashi, Akihiko Takasaki, Kazuhiro Suzuki, Miwa Morita, Gene Kurosawa, Sari Fujiyama, Susumu Tsustumi, Keiko Ogawa, Kazuki Matsuda, Chiho Muramatsu, Yoshitaka Iba, Mariko Sumitomo, Masachika Azuma, Yoshinori Ukai, Kazuhiro Morishita
  • Publication number: 20110014211
    Abstract: Provided herein is a means which is effective for botulism diseases and the prevention of the botulism diseases. Specifically provided is a plurality of human anti-botulinum toxin type-A antibodies having different epitopes from one another. Also specifically provided is a composition for neutralizing botulinum toxin type-A, which comprises a combination of two or more of the antibodies and which has a high neutralizing activity.
    Type: Application
    Filed: January 23, 2009
    Publication date: January 20, 2011
    Applicants: Institute for Antibodies Co., Ltd., Japan as Represented by Director-General of National Institute of Infectious Disesases, Osaka Prefecture University Public Corporation
    Inventors: Masachika Azuma, Motohide Takahashi, Shunji Kozaki, Masafumi Mukamoto, Tomoko Kohda, Gene Kurosawa, Yoshikazu Kurosawa
  • Publication number: 20090203538
    Abstract: It is intended to provide a method whereby a plural number of antibodies against cell surface antigens are quickly classified and to provide a method whereby antigens of the thus classified antibodies are quickly identified. Further, it is intended to provide a method of promoting the utilization of the useful data obtained by the above methods. Furthermore, it is intended to provide an antibody which is effective in treating or diagnosing cancer.
    Type: Application
    Filed: January 9, 2009
    Publication date: August 13, 2009
    Applicant: Institute for Antibodies Co., Ltd.
    Inventors: Atsushi Sugioka, Mototaka Sugiura, Yasushi Akahori, Nobuhiro Hayashi, Akihiko Takasaki, Miwa Morita, Gene Kurosawa, Mariko Sumitomo, Susumu Tsutsumi, Keiko Ogawa, Kazuki Matsuda, Chiho Muramatsu, Noriko Satou, Masachika Azuma, Yoshinori Ukai, Kazuhiro Suzuki, Yoshikazu Kurosawa, Miho Tanaka, Mamoru Shiraishi
  • Publication number: 20090053243
    Abstract: It is intended to clarify a molecule which is available as a target in treating or diagnosing cancer and utilize the molecule in the medical field or the research field. By treating IgSF4, which has been identified as a molecule specifically expressed in lung cancer cells, with an antibody, and ADCC activity is exerted. Based on this finding, an anti-IgSF4 antibody is provided as a means efficacious in treating cancer, etc.
    Type: Application
    Filed: February 22, 2006
    Publication date: February 26, 2009
    Applicant: Institute for Antibodies Co., Ltd
    Inventors: Yoshikazu Kurosawa, Yasushi Akahori, Nobuhiro Takahashi, Atsushi Sugioka, Nobuhiro Hayashi, Akihiko Takasaki, Kazuhiro Suzuki, Miwa Morita, Gene Kurosawa, Sari Fujiyama, Susumu Tsustumi, Keiko Ogawa, Kazuki Matsuda, Chiho Muramatsu, Yoshitaka Iba, Mariko Sumitomo, Masachika Azuma, Yoshinori Ukai, Kazuhiro Morishita